DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 148 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $7,359,000 | -10.9% | 216,557 | -4.0% | 0.23% | -7.7% |
| Q2 2021 | $8,258,000 | -19.6% | 225,567 | -1.5% | 0.25% | -25.5% |
| Q1 2021 | $10,270,000 | -57.7% | 229,040 | -46.2% | 0.33% | -59.0% |
| Q4 2020 | $24,292,000 | +88.4% | 425,661 | +69.3% | 0.80% | +43.6% |
| Q3 2020 | $12,896,000 | -16.0% | 251,381 | -2.2% | 0.56% | -18.6% |
| Q2 2020 | $15,350,000 | – | 257,031 | – | 0.69% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $69,030,000 | 15.95% |
| SV Health Investors, LLC | 449,951 | $25,679,000 | 12.37% |
| Sunesis Advisors, LLC | 96,299 | $5,496,000 | 4.45% |
| Redmile Group, LLC | 4,437,968 | $253,275,000 | 3.07% |
| Consonance Capital Management LP | 484,671 | $27,660,000 | 2.58% |
| SECTORAL ASSET MANAGEMENT INC | 488,842 | $27,898,000 | 1.97% |
| Opaleye Management Inc. | 222,000 | $12,670,000 | 1.66% |
| Eversept Partners, LP | 246,240 | $14,052,917 | 1.65% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 38,620 | $2,204,000 | 1.28% |
| Avoro Capital Advisors LLC | 1,300,000 | $74,191,000 | 1.28% |